Physician profile
Lisa Dishongh
NPI 1912001900
$3,529.99
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $897 · 2020: $446 · 2021: $676 · 2022: $986 · 2023: $524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $524.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $907.02 | 2019-2023 | Lo Loestrin Fe, Orilissa, Liletta |
| Bayer Healthcare Pharmaceuticals INC. | $256.29 | 2019-2023 | |
| Therapeuticsmd, INC. | $250.69 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $202.87 | 2021-2023 | |
| Pfizer INC. | $199.83 | 2019-2023 | |
| Urovant Sciences INC | $178.95 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $173.61 | 2023 | Gemtesa, Myfembree |
| Avion Pharmaceuticals | $169.77 | 2019-2022 | |
| Evofem Biosciences, INC. | $130.03 | 2020-2022 | |
| Exeltis, USA INC. | $118.14 | 2019-2021 | |
| Myovant Sciences INC. | $101.44 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $95.08 | 2020-2023 | Gardasil 9 |
| Agile Therapeutics, INC. | $94.80 | 2021-2022 | |
| Astellas Pharma US INC | $90.22 | 2019-2020 | |
| Duchesnay USA Incorporated | $79.15 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $62.18 | 2019-2022 | |
| Scynexis, INC. | $57.60 | 2022 | |
| Allergan, INC. | $56.09 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $39.59 | 2019 | |
| Mission Pharmacal Company | $38.36 | 2019-2020 | |
| Organon LLC | $31.88 | 2022 | |
| Lupin INC. | $31.36 | 2019-2020 | |
| Daiichi Sankyo INC. | $29.96 | 2019 | |
| Amag Pharmaceuticals, INC. | $27.87 | 2019 | |
| Millicent US INC | $25.75 | 2019 | |
| Exact Sciences Corporation | $24.94 | 2023 | Cologuard Collection Kit |
| Coloplast Corp | $18.38 | 2019 | |
| Mallinckrodt Enterprises LLC | $13.72 | 2019 | |
| Olympus America INC. | $12.99 | 2019 | |
| Ferring Pharmaceuticals INC. | $11.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Dishongh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.